Padrão de fundo

Flumazenil altan 0,1 mg/ml solucion inyectable efg

About the medicine

Como usar Flumazenil altan 0,1 mg/ml solucion inyectable efg

Introduction

Package Insert: Information for the User

FLUMAZENIL ALTAN 0.1 mg/mL Injectable Solution EFG

Read the entire package insert carefully before starting to use the medication

  • Keep this package insert, as you may need to refer to it again.
  • If you have any questions, consult your doctor or pharmacist.
  • If you experience any adverse effects, consult your doctor or nurse, even if they are not listed in this package insert. See section 4

1. What is Flumazenil Altan and what is it used for

Flumazenil has an opposite action and neutralizes the effect of benzodiazepines (compounds used for their sedative, muscle relaxant, and anticonvulsant properties) and belongs to the group of antidotes. Its action consists of interrupting the nerve conduction produced by benzodiazepines by competing with them in their union to the nervous system receptors.

This medication is indicated to neutralize totally or partially the central sedative effect of benzodiazepines. Consequently, it should be used in anesthesia and intensive care in the following indications:

In anesthesia:

  • To end anesthesia produced by benzodiazepines in hospitalized patients.
  • To end the calming or sedative effect produced by benzodiazepines in patients who have undergone tests for diagnosis or identification of a disease, or in short treatments in the hospital or outpatient setting.

In intensive care:

  • To reverse the effect of benzodiazepines at the central nervous system level and allow for the recovery of spontaneous breathing.

To diagnose or treat intoxications or overdoses caused solely or mainly by benzodiazepines.

2. Before Using Flumazenil Altan

No use FLUMAZENIL:

  • In case of being allergic to flumazenil or to any of the other components of this medication.
  • In cases of intoxications due to two drugs such as benzodiazepines and tricyclic antidepressants (compounds used in the treatment of depression), because the toxicity of antidepressants may be masked by the protective effects of benzodiazepines.
  • If benzodiazepines have been used as treatment for a potentially life-threatening disease (for example, control of intracranial pressure or status epilepticus).

Warnings and precautions for use:

  • It is not recommended to use in children for indications other than terminating the calming or sedative effect. This also applies to children under one year in which flumazenil should not be used unless the potential benefits outweigh the possible risks.
  • If the patient does not wake up because it may be due to another cause. If used to terminate anesthesia after surgery, it should not be administered until the muscle-relaxing effect has ended. Since the action of flumazenil is normally shorter than that of benzodiazepines and the sedative effect may reappear, the patient should be closely monitored, preferably in the intensive care unit, until the effect of flumazenil has disappeared.
  • In cases of patients at risk, the advantages of sedation with benzodiazepines should be weighed against the disadvantages that would occur if a rapid awakening were to occur. In some patients, such as those with heart problems, a certain degree of sedation may be preferred over complete awakening.
  • High doses (over 1 mg) of flumazenil should be avoided in patients receiving long-term treatment with benzodiazepines, as this could cause withdrawal symptoms.
  • The dose of flumazenil should be carefully adjusted in patients who have anxiety before surgery or who have a history of anxiety or anxiety disorders.
  • If pain occurs after surgery.
  • If you have been taking high doses of benzodiazepines for a long time. In patients with epilepsy treated with benzodiazepines for a prolonged period, sudden neutralization of the effect could cause seizures.
  • If you have severe brain injuries, as it may increase intracranial pressure.
  • If you have dependence or benzodiazepine withdrawal syndrome, treatment with flumazenil is not recommended.
  • If you have a history of panic disorders.
  • Due to the increased frequency of tolerance and dependence to benzodiazepines in patients with alcoholism and dependence on other drugs, flumazenil should be used with caution in this population.
  • Patients treated with this medication to neutralize the effects of benzodiazepines should be monitored at all times necessary, depending on the duration of the benzodiazepine effect, to prevent the occurrence of breathing problems, drowsiness, or any other effect due to the benzodiazepine.

Use of other medications:

Inform your doctor or pharmacist if you are taking or have recently taken any other medication, including those purchased without a prescription.

This medication counteracts the effects of benzodiazepines in the Central Nervous System; the action of other medications, such as zopiclone (used in the treatment of sleep disorders), triazolopyridazines (non-benzodiazepine anxiolytics), and others, is also counteracted by flumazenil.

Pregnancy and lactation

Consult your doctor or pharmacist before taking a medication.

If you are pregnant, you will only use this medication under strict indication from your doctor.

The parenteral administration of flumazenil in emergencies during lactation is not contraindicated.

Driving and use of machines:

Although after intravenous administration of this medication, patients may be awake and conscious, they should abstain from performing hazardous activities that require full mental concentration (such as operating hazardous machinery or driving vehicles) for 24 hours, as the effects of the previously taken or administered benzodiazepine, such as sedation, may reappear.

Important information about one of the components of Flumazenil

This medication contains 9 mg of sodium per ml; this is, 45 mg per 5 ml ampoule and 90 mg per 10 ml ampoule of injectable solution, so it should be taken into account in patients with a low-sodium diet.

3. How to Use Flumazenil Altan

This medication is presented as an injectable solution in ampoules. Each package contains 5 ampoules.

Follow these instructions unless your doctor has given you different instructions.

This medication is recommended for use only intravenously and should be administered by an anesthesiologist or experienced doctor.

Your doctor will indicate your daily dose and the duration of your treatment.

Since the duration of action of some benzodiazepines exceeds that of this medication, repeated doses may be required if sedation reappears after waking up.

Adults

During anesthesia

The recommended initial dose is 0.2 mg i.v., administered in 15 seconds. If the desired level of consciousness is not obtained within 60 seconds after the first i.v. administration, a new dose of 0.1 mg may be injected, repeating it, if necessary, at intervals of 60 seconds, up to a total dose of 1 mg. The usual dose is between 0.3 and 0.6 mg, but individual requirements may vary significantly, depending on the dose and duration of the benzodiazepine effect and patient characteristics.

Intensive care units

The recommended initial dose is 0.2 mg administered intravenously over 15 seconds. If, after 60 seconds, the desired level of consciousness is not obtained, an additional dose of 0.1 mg may be injected and repeated at intervals of 60 seconds, up to a total dose of 2 mg or until the patient wakes up.

If sedation reappears, a useful intravenous infusion of 0.1-0.4 mg/h may be useful. The infusion rate should be adjusted individually to achieve the desired level of consciousness.

If, after repeated dosing, no evident effect is obtained on consciousness and respiration, it should be considered that the intoxication is not caused by benzodiazepines.

The infusion should be interrupted every 6 hours to check if the patient is sedated again.

To avoid the appearance of abstinence in patients treated for a long period with high doses of benzodiazepines in the intensive care unit, the dose of flumazenil should be evaluated individually and the injection should be administered slowly.

Children over 1 year:

To eliminate sedation caused by benzodiazepines in children over 1 year, the recommended initial dose is 0.01 mg/kg (up to 0.2 mg) administered intravenously over 15 seconds. If consciousness is not recovered after 45 seconds, new injections of 0.01 mg/kg (up to 0.2 mg) may be administered, if necessary, every 60 seconds (up to a maximum of 4 times) until a maximum total dose of 0.05 mg/kg or 1 mg (the lower dose should be used). The dose should be calculated individually for each patient.

Use in children under 1 year:

There are not enough data on the use of flumazenil in children under 1 year. Your doctor will consider whether the potential benefits in children under 1 year outweigh any possible risks.

Use in people over 65 years:

Use in people over 65 years should be done with caution, as this population is generally more sensitive to the effects of medications.

Patients with liver and kidney function abnormalities:

In patients with liver function abnormalities, the elimination of flumazenil may be delayed, so it is recommended to reduce doses when repeated doses are administered (not for the initial dose).

No dose adjustments are required in patients with kidney problems.

If you use more FUMAZENIL ALTAN than you should:

If you think you have been given too much flumazenil, you may not notice any effect, however, it is recommended to consult your doctor or pharmacist as soon as possible.

If you have any other questions about the use of this product, ask your doctor or pharmacist. In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone: (91) 562 04 20.

If you have any other questions about the use of this medication, ask your doctor or nurse.

4. Possible Adverse Effects

Like all medications, this medication may have adverse effects, although not everyone will experience them.

The following adverse effects have been described:

Very frequent: may affect more than 1 in 10 patients/people:

  • nausea (during anesthesia)

Frequent (may affect up to 1 in 10 patients):

  • allergic reactions
  • anxiety, mood changes, insomnia, drowsiness
  • dizziness, headache, nervousness, tremors, dry mouth, excessively deep and prolonged breathing, speech alterations, paresthesia.
  • double vision, strabismus, increased tearing
  • rapid heart rate
  • flushing of the face, decreased blood pressure, decreased blood pressure upon changing position, temporary increase in blood pressure (upon waking)
  • vomiting (during anesthesia), hiccups.
  • sweating
  • fatigue, pain at the injection site.

Rare: may affect between 1 and 10 in 1,000 patients/people

  • abnormal hearing.
  • increased or decreased heart rate, premature heart beat.
  • difficulty breathing, cough, nasal congestion, chest pain.
  • chills.

In patients treated for a long time with benzodiazepines, flumazenil may produce what is known as withdrawal syndrome, whose symptoms are: tension, agitation, anxiety, confusion, hallucinations, tremors, and seizures.

The adverse effects that may appear in children are quite similar to those of adults. When flumazenil is used to eliminate central sedation, abnormal crying, agitation, and aggressive behavior may occur.

If these adverse effects or any other not described in this prospectus are observed, consult with your doctor or pharmacist.

5. Flumazenil Altan Storage.

Keep this medication out of the sight and reach of children.

No special storage conditions are required.

Do not dispose of medications through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.

Expiration Date:

Do not use this medication after the expiration date indicated on the packaging.

6. Additional Information

Composition of FLUMAZENIL ALTAN

The active ingredient is Flumazenil.

Each ml contains 0.1 mg of flumazenil.

1 vial with 5 ml contains 0.5 mg of flumazenil

1 vial with 10 ml contains 1 mg of flumazenil

The other components (excipients) are: sodium edetate, glacial acetic acid, sodium chloride, sodium hydroxide, and water for injectable preparations.

Appearance of the product and contents of the package

5 glass vials with 0.5 mg of active ingredient in 5 ml of aqueous solution or with 1 mg of active ingredient in 10 ml of aqueous solution.

Marketing Authorization Holder:

Altan Pharmaceuticals, S.A.

C/ Cólquide nº 6. Portal 2, 1st floor,

Edificio Prisma

28230 - Las Rozas. MADRID

Spain

Responsible for manufacturing:

Laboratorio Reig Jofré, S.A.

c/ Gran Capitán, nº 10.

08970 Sant Joan Despí. (Barcelona)

Spain

This leaflet was revised in July 2019

The detailed information of this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es

This information is intended solely for doctors or healthcare professionals:

Any unused solution must be discarded.

The medication must be visually inspected. It should only be used if the solution is transparent and practically free of particles.

When flumazenil is to be used for infusion, it must be diluted before infusion. Flumazenil should only be diluted with a 9 mg/ml sodium chloride solution (0.9%), a 50 mg/ml dextrose solution (5%), or a Ringer Lactate solution. The compatibility between flumazenil and other injectable solutions has not been established.

Solutions for intravenous infusion or syringes filled with a flumazenil solution must be discarded after 24 hours.

From a microbiological point of view, the product must be used immediately. If not used immediately, the time and storage conditions before use are the responsibility of the user and should not normally exceed 24 hours between 2 and 8°C, unless the dilution has been made in conditions appropriate to prevent contamination.

Consulte um médico online

Tem perguntas sobre este medicamento ou sintomas? Obtenha orientação de um médico qualificado, de forma prática e segura.

0.0(9)
Doctor

Anna Moret

Dermatologia18 anos de experiência

A Dra. Anna Moret é dermatologista e dermatovenerologista certificada, especializada em dermatologia para adultos e crianças, venereologia, cuidados estéticos com a pele e medicina geral. As suas consultas são baseadas em evidências e adaptadas às necessidades dermatológicas individuais de cada paciente.

A Dra. Moret realiza avaliação e tratamento especializado para:

• Problemas de pele como eczema, acne, rosácea, dermatite e psoríase • Queda de cabelo, caspa e dermatite seborreica do couro cabeludo • Dermatologia pediátrica — do recém-nascido à adolescência • Infeções sexualmente transmissíveis (DSTs) e dermatovenereologia • Envelhecimento da pele e tratamentos estéticos não invasivos • Alergias cutâneas e reações de hipersensibilidade • Avaliação de sinais, lesões cutâneas e rastreio de cancro de pele • Aconselhamento sobre cuidados com a pele e rotinas personalizadas com dermocosméticos

Combinando conhecimentos em dermatologia e medicina geral, a Dra. Moret oferece um cuidado abrangente, focado tanto na saúde da pele como nas possíveis causas associadas. Possui também certificação do Canadian Board of Aesthetic Medicine, assegurando uma abordagem estética alinhada com os padrões internacionais.

CameraMarcar consulta online
5.0(56)
Doctor

Alina Tsurkan

Medicina familiar12 anos de experiência

A Dra. Alina Tsurkan é médica de clínica geral e familiar licenciada em Portugal, oferecendo consultas online para adultos e crianças. O seu trabalho centra-se na prevenção, diagnóstico preciso e acompanhamento a longo prazo de condições agudas e crónicas, com base em medicina baseada na evidência.

A Dra. Tsurkan acompanha pacientes com uma ampla variedade de queixas de saúde, incluindo: • Infeções respiratórias: constipações, gripe, bronquite, pneumonia, tosse persistente • Problemas otorrinolaringológicos: sinusite, amigdalite, otite, dor de garganta, rinite alérgica • Queixas oftalmológicas: conjuntivite alérgica ou infeciosa, olhos vermelhos, irritação ocular • Problemas digestivos: refluxo ácido (DRGE), gastrite, síndrome do intestino irritável (SII), obstipação, inchaço abdominal, náuseas • Saúde urinária e reprodutiva: infeções urinárias, cistite, prevenção de infeções recorrentes • Doenças crónicas: hipertensão, colesterol elevado, controlo de peso • Queixas neurológicas: dores de cabeça, enxaquecas, distúrbios do sono, fadiga, fraqueza geral • Saúde infantil: febre, infeções, problemas digestivos, seguimento clínico, orientação sobre vacinação

Outros serviços disponíveis: • Atestados médicos para a carta de condução (IMT) em Portugal • Aconselhamento preventivo e consultas de bem-estar personalizadas • Análise de resultados de exames e relatórios médicos • Acompanhamento clínico e revisão de medicação • Gestão de comorbilidades e situações clínicas complexas • Prescrições e documentação médica à distância

A abordagem da Dra. Tsurkan é humanizada, holística e baseada na ciência. Trabalha lado a lado com cada paciente para desenvolver um plano de cuidados personalizado, centrado tanto nos sintomas como nas causas subjacentes. O seu objetivo é ajudar cada pessoa a assumir o controlo da sua saúde com acompanhamento contínuo, prevenção e mudanças sustentáveis no estilo de vida.

CameraMarcar consulta online
5.0(90)
Doctor

Andrei Popov

Clínica geral6 anos de experiência

O Dr. Andrei Popov é um médico licenciado em medicina geral e especialista em controlo da dor, com prática clínica em Espanha. Oferece consultas online para adultos com dor aguda ou crónica, bem como para uma variedade de queixas médicas comuns.

É especializado no diagnóstico e tratamento de condições dolorosas que afetam a qualidade de vida, incluindo: • Dor crónica com duração superior a 3 meses • Enxaquecas e dores de cabeça recorrentes • Dores no pescoço, costas, região lombar e articulações • Dor pós-traumática após lesões ou cirurgias • Dor neuropática, fibromialgia e nevralgias

Além do controlo da dor, o Dr. Popov também presta cuidados médicos em casos como: • Infeções respiratórias (constipações, bronquite, pneumonia) • Hipertensão arterial e condições metabólicas, como a diabetes • Acompanhamento preventivo e check-ups de rotina

As consultas online duram até 30 minutos e incluem uma avaliação detalhada dos sintomas, plano de tratamento personalizado e seguimento médico, se necessário.

A abordagem do Dr. Popov baseia-se na medicina baseada na evidência, com atenção individualizada à história clínica, estilo de vida e necessidades específicas de cada paciente.

CameraMarcar consulta online
5.0(21)
Doctor

Yevgen Yakovenko

Cirurgia geral11 anos de experiência

Dr. Yevgen Yakovenko é um cirurgião e clínico geral licenciado em Espanha e Alemanha. É especializado em cirurgia geral, pediátrica e oncológica, medicina interna e controlo da dor. Oferece consultas online para adultos e crianças, combinando precisão cirúrgica com acompanhamento terapêutico. O Dr. Yakovenko acompanha pacientes de vários países e presta cuidados médicos em ucraniano, russo, inglês e espanhol.

Áreas de especialização médica: • Dor aguda e crónica: cefaleias, dores musculares e articulares, dores nas costas, dores abdominais, dor pós-operatória. Identificação da causa, plano de tratamento e seguimento. • Medicina interna: coração, pulmões, trato gastrointestinal, sistema urinário. Controlo de doenças crónicas, alívio de sintomas, segunda opinião. • Cuidados pré e pós-operatórios: avaliação de riscos, apoio na tomada de decisão, acompanhamento após cirurgia, estratégias de reabilitação. • Cirurgia geral e pediátrica: hérnias, apendicite, doenças congénitas. Cirurgias programadas e de urgência. • Traumatologia: contusões, fraturas, entorses, lesões de tecidos moles, tratamento de feridas, pensos, encaminhamento para cuidados presenciais quando necessário. • Cirurgia oncológica: revisão diagnóstica, planeamento do tratamento, acompanhamento a longo prazo. • Interpretação de exames: análise de ecografias, TAC, ressonâncias magnéticas e radiografias. Planeamento cirúrgico com base nos resultados. • Segundas opiniões e navegação médica: esclarecimento de diagnósticos, revisão de tratamentos atuais, apoio na escolha do melhor caminho terapêutico.

Experiência e formação: • Mais de 12 anos de experiência clínica em hospitais universitários na Alemanha e em Espanha • Formação internacional: Ucrânia – Alemanha – Espanha • Membro da Sociedade Alemã de Cirurgiões (BDC) • Certificação em diagnóstico por imagem e cirurgia robótica • Participação ativa em congressos médicos e investigação científica internacionais

O Dr. Yakovenko explica temas médicos complexos de forma clara e acessível. Trabalha em parceria com os pacientes para analisar situações clínicas e tomar decisões fundamentadas. A sua abordagem baseia-se na excelência clínica, rigor científico e respeito individual.

Se tem dúvidas sobre um diagnóstico, está a preparar-se para uma cirurgia ou quer discutir resultados de exames, o Dr. Yakovenko pode ajudá-lo a avaliar as suas opções e avançar com confiança.

CameraMarcar consulta online
Ver todos os médicos

Receba novidades da plataforma e promoções exclusivas

Fique a par das atualizações da Oladoctor e receba promoções exclusivas para subscritores.

Siga-nos nas redes sociais
FacebookInstagramTikTok